In the last week, regulatory bodies in both India and China have approved inhaled vaccines for covid-19. The companies behind these vaccines say that they’ll boost the immune responses of people who... Read more »

So then if I extend that. Two years ago, we launched DevCloud, UBS DevCloud, which is effectively an open ecosystem built on public cloud, where all our software engineers can have a... Read more »

2 The Merge is crypto’s greatest test to dateIf it’s successful, it could solve many of the industry’s problems. (Economist $)+ The Ethereum upgrade will greatly improve its security. (Protocol) 3 Doomscrolling... Read more »

“They all graduated from Tsinghua and went on to the University of Southern California or similar well-known universities,” Li says. “Besides that, they all worked at a certain company in Shanghai. Obviously,... Read more »

Companies that are stymied by the pace of change are usually limited by monolithic architecture, legacy systems, and outdated processes. Many of these tools have been functional—or simply passable—for years but have... Read more »

“Brain injury patients would be the first [candidates],” says Song. Such injuries tend to affect specific regions of the brain. Injuries to the hippocampus would be easier to target than degenerative diseases... Read more »

The news: A unique form of brain stimulation appears to boost people’s ability to remember new information—by mimicking the way our brains create memories. The “memory prosthesis,” which involves inserting an electrode... Read more »

Long before Alexander Cohen—or anyone else—had heard of the alpha, delta, or omicron variants of covid-19, he and his graduate school advisor Pamela Bjorkman were doing the research that might soon make... Read more »

The key to the universal vaccine is the mosaic nanoparticle with so many different viral fragments clustered in close proximity on its surface. The immune system’s B cells, which generate specific antibodies,... Read more »